- Home
- FROG vs ARWR Comparison
FROG vs ARWR Comparison
Compare FROG & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FROG
- ARWR
- Stock Information
- Founded
- FROG 2008
- ARWR 2003
- Country
- FROG United States
- ARWR United States
- Employees
- FROG N/A
- ARWR N/A
- Industry
- FROG Computer Software: Prepackaged Software
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- FROG Technology
- ARWR Health Care
- Exchange
- FROG Nasdaq
- ARWR Nasdaq
- Market Cap
- FROG 5.4B
- ARWR 5.1B
- IPO Year
- FROG 2020
- ARWR 1993
- Fundamental
- Price
- FROG $50.29
- ARWR $39.95
- Analyst Decision
- FROG Strong Buy
- ARWR Strong Buy
- Analyst Count
- FROG 17
- ARWR 8
- Target Price
- FROG $52.47
- ARWR $47.75
- AVG Volume (30 Days)
- FROG 767.3K
- ARWR 1.9M
- Earning Date
- FROG 11-06-2025
- ARWR 11-25-2025
- Dividend Yield
- FROG N/A
- ARWR N/A
- EPS Growth
- FROG N/A
- ARWR N/A
- EPS
- FROG N/A
- ARWR N/A
- Revenue
- FROG $474,761,000.00
- ARWR $572,976,000.00
- Revenue This Year
- FROG $21.23
- ARWR $21,287.22
- Revenue Next Year
- FROG $15.90
- ARWR N/A
- P/E Ratio
- FROG N/A
- ARWR N/A
- Revenue Growth
- FROG 21.97
- ARWR 2816.20
- 52 Week Low
- FROG $27.00
- ARWR $9.57
- 52 Week High
- FROG $51.94
- ARWR $40.29
- Technical
- Relative Strength Index (RSI)
- FROG 60.94
- ARWR 68.38
- Support Level
- FROG $47.03
- ARWR $36.73
- Resistance Level
- FROG $49.35
- ARWR $39.56
- Average True Range (ATR)
- FROG 1.29
- ARWR 1.67
- MACD
- FROG 0.20
- ARWR -0.21
- Stochastic Oscillator
- FROG 99.58
- ARWR 94.03
About FROG JFrog Ltd.
JFrog Ltd provides an end-to-end, hybrid, universal DevOps Platform that powers and controls the software supply chain, enabling organizations to continuously and securely deliver software updates across any system. Its product portfolio includes JFrog Artifactory; JFrog Pipelines; JFrog Xray; JFrog Distribution; JFrog Artifactory Edge; JFrog Mission Control and JFrog Insight. Geographically, it derives a majority of revenue from Israel and also has its presence in United States, India and other regions.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.